These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11267175)

  • 1. Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf.
    Abouljoud M; Kumar MS; Brayman K; Emre S; Bynon SJ
    Transplant Proc; 2001; 33(1-2):1027-8. PubMed ID: 11267175
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR;
    Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract]   [Full Text] [Related]  

  • 4. Conversion from tacrolimus to Neoral in liver and kidney transplant recipients.
    Ott R; Bussenius-Kammerer M; Scholz D; Neuhaus R; Tolba RH; Fricke L; Müller V
    Transplant Proc; 2001; 33(7-8):3166-8. PubMed ID: 11750359
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
    Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
    Transplant Proc; 1998 Jun; 30(4):1401-2. PubMed ID: 9636566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
    Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
    Transplant Proc; 1998 Aug; 30(5):1830-2. PubMed ID: 9723299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from cyclosporine to FK 506 as rescue therapy in renal transplantation with poorly steroid-responsive acute rejection.
    Morales E; Andrés A; Herrero JC; Dominguez-Gil B; Carreño A; Morales JM; Hernández E; Ortuño T; Praga M
    Transplant Proc; 1999 Sep; 31(6):2248-9. PubMed ID: 10500562
    [No Abstract]   [Full Text] [Related]  

  • 10. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus rescue therapy for renal transplant rejection.
    Jordan ML; Shapiro R; Naraghi R; Smith D; Vivas C; Gritsch HA; Scantlebury V; Randhawa P; Demetris AJ; Fung JJ; Starzl TE
    Transplant Proc; 1996 Aug; 28(4):2119-20. PubMed ID: 8769174
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases.
    Morris-Stiff G; Singh J; Ostrowski K; Balaji V; Moore R; Darby C; Lord R; Jurewicz WA
    Transplant Proc; 1998 Jun; 30(4):1295-6. PubMed ID: 9636525
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience with neoral cyclosporine through the oral route in liver transplantation.
    Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C
    Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy.
    Ben-Ari Z; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
    Transplant Proc; 2000 Jun; 32(4):709-10. PubMed ID: 10856553
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months.
    Budde K; Fritsche L; Smettan S; Schönberger B; Loening SA; Mai I; Bauer S; Waiser J; Neumayer HH
    Transplant Proc; 1998 Jun; 30(4):1238-9. PubMed ID: 9636503
    [No Abstract]   [Full Text] [Related]  

  • 16. Basiliximab in the therapy of acute rejection after organ transplantation.
    Chariat MN; Erren M; Chariat M; Deng M; Wolters HH; Dietl KH
    Transplant Proc; 2001 May; 33(3):2380. PubMed ID: 11377567
    [No Abstract]   [Full Text] [Related]  

  • 17. Neoral rescue therapy in transplant patients with intolerance to tacrolimus.
    Abouljoud MS; Kumar MS; Brayman KL; Emre S; Bynon JS;
    Clin Transplant; 2002 Jun; 16(3):168-72. PubMed ID: 12010138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-center comparison between primary immunosuppression based on neoral cyclosporine and tacrolimus for renal transplantation.
    Pascual J; Marcén R; Burgos FJ; Tenorio MT; Merino JL; Arambarri M; Villafruela JJ; Liaño F; Mampaso F; Ortuño J
    Transplant Proc; 2002 Feb; 34(1):94-5. PubMed ID: 11959200
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L; Wang Y; Fu SJ; Cheng XJ
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression.
    Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimaräes S
    Transplant Proc; 2000 Dec; 32(8):2636-8. PubMed ID: 11134735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.